<
AI
Automation
Science
Innovation
Open Source
Blockchain
Social Media
Startups
Culture
Cloud
>

Destination
Weight loss drugs can help employers cut health care costs, study says

Covering the cost of pricey GLP-1 weight loss drugs could pay off for employers by cutting overall medical spending for people taking the medications, but not until year two, according to a massive analysis of health insurance claims by Aon released on Wednesday.Read more... [...]

Discover Copy
Rating

Innovation

Pricing

Technology

Usability

We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.

Destination
The best smart scales for 2025

The New Year is here and there’s no better time to kickstart those health and fitness goals. Whether you’re looking to shed a few holiday pounds, track your muscle gains or simply stay on top of a [...]

Match Score: 88.59

thenextweb
Verdiva launches with $410M for weight loss drugs to challenge Ozempic, Wegovy

London-headquartered biotech startup Verdiva has emerged from stealth with a whopping $410mn for a new range of drugs aimed at tackling the obesity epidemic. It’s one of Europe’s largest-ever biot [...]

Match Score: 65.70

Destination
Eli Lilly is stepping up its fight against copycat weight-loss drugs

In its continuing war against copycat drugs, Eli Lilly (LLY) said on Wednesday that it filed suits against four telehealth companies that offer cheaper versions of its blockbuster GLP-1 weight loss dr [...]

Match Score: 49.23

Destination
Weight loss drugs are squeezing the food industry

The revolutionary GLP-1 class of weight loss drugs are racking up blockbuster sales at a pace rarely seen in the pharmaceutical industry. But the pharma industry’s gain is the food industry’s loss [...]

Match Score: 46.70

Destination
Cigna is putting a cap on weight loss drug costs

Getting access to popular weight loss drugs will be simpler and cheaper for some.Read more... [...]

Match Score: 42.18

Destination
Eli Lilly's Zepbound beat Novo Nordisk’s Wegovy in a big weight loss drug study

Eli Lilly’s (LLY) and Novo Nordisk’s (NVO) weight loss drugs went head-to-head in a weight loss study for the first time — and Eli Lilly’s drug came out on top.Read more... [...]

Match Score: 41.08

Destination
Seattle Ultrasonics C-200 review: This is the future of kitchen knives

There’s a type of knife tech often seen in science fiction that revolves around vibrating a blade to increase its sharpness. We’ve seen examples of this in franchises like Star Wars (vibroblades), [...]

Match Score: 39.80

Destination
Wegovy's price cut, Amgen's Ozempic competitor, and Big Pharma's tax cut: Pharma news roundup

Novo Nordisk just cut the price of its weight-loss drug, Wegovy, by more than half for patients who pay without insurance. Amgen (AMGN) announced this week that it has begun two late-stage clinical tr [...]

Match Score: 39.79

Destination
Noom is offering microdoses of compounded Wegovy for weight loss

Noom will start offering microdoses of compounded Wegovy (NVO), the blockbuster weight-loss drug, as the digital health company continues to adapt to the growing demand for affordable weight-loss solu [...]

Match Score: 39.23